Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus
- PMID: 9357051
- DOI: 10.1016/s0196-9781(97)00025-9
Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus
Abstract
To map the proteolytic enzymes metabolizing dynorphins in brain structures, size-exclusion chromatography linked to electrospray ionization mass spectrometry was used. Enzymes extracted from rat hippocampus, striatum, and substantia nigra were tested for their capability of converting dynorphin-related peptides. Dynorphin A was the most resistant to proteolytic conversion, whereas Big dynorphin and dynorphin B-29 were slowly converted to dynorphin A and dynorphins A and B, respectively. Dynorphin B and alpha-neoendorphin were the least resistant. Dynorphin B was rapidly converted to Leu-enkephalin in the striatum and hippocampus but to Leu-enkephalin-Arg6 in the substantia nigra. alpha-Neoendorphin was converted to Leu-enkephalin in all tissues investigated.
Similar articles
-
Processing of prodynorphin-derived peptides in striatal extracts. Identification by electrospray ionization mass spectrometry linked to size-exclusion chromatography.Life Sci. 1995;57(2):123-9. doi: 10.1016/0024-3205(95)00253-3. Life Sci. 1995. PMID: 7603294
-
Dynorphinergic pathways of Leu-enkephalin production in the rat brain.Neuropeptides. 1985 Feb;5(4-6):441-4. doi: 10.1016/0143-4179(85)90049-6. Neuropeptides. 1985. PMID: 2860603
-
Regulation of striatonigral prodynorphin peptides by dopaminergic agents.Brain Res. 1990 Jun 4;518(1-2):244-56. doi: 10.1016/0006-8993(90)90977-j. Brain Res. 1990. PMID: 1975215
-
Dynorphins in Development and Disease: Implications for Cardiovascular Disease.Curr Mol Med. 2020;20(4):259-274. doi: 10.2174/1566524019666191028122559. Curr Mol Med. 2020. PMID: 31746302 Free PMC article. Review.
-
Inhibitors of neuropeptide peptidases engaged in pain and drug dependence.Neuropharmacology. 2020 Sep 15;175:108137. doi: 10.1016/j.neuropharm.2020.108137. Epub 2020 Jun 9. Neuropharmacology. 2020. PMID: 32526240 Review.
Cited by
-
The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder.Neuropharmacology. 2023 Mar 1;225:109376. doi: 10.1016/j.neuropharm.2022.109376. Epub 2022 Dec 11. Neuropharmacology. 2023. PMID: 36516892 Free PMC article. Review.
-
Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease.PLoS One. 2011;6(9):e25653. doi: 10.1371/journal.pone.0025653. Epub 2011 Sep 30. PLoS One. 2011. PMID: 21984936 Free PMC article.
-
Effect of prodynorphin-derived opioid peptides on the ovulatory luteinizing hormone surge in the proestrous rat.Endocrine. 2002 Jun;18(1):27-32. doi: 10.1385/ENDO:18:1:27. Endocrine. 2002. PMID: 12166621
-
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.Cell Mol Life Sci. 2012 Mar;69(6):857-96. doi: 10.1007/s00018-011-0844-x. Epub 2011 Oct 16. Cell Mol Life Sci. 2012. PMID: 22002579 Free PMC article. Review.
-
L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.Mol Cell Proteomics. 2011 Oct;10(10):M111.009308. doi: 10.1074/mcp.M111.009308. Epub 2011 Jul 6. Mol Cell Proteomics. 2011. PMID: 21737418 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources